sec filing
TR
NASDAQ · TRDA
Entrada Therapeutics, Inc.
Healthcare · Biotechnology
$5.48
Down-$0.06 (-1.09%)
Updated Oct 6, 2026, 11:18 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 413.53M
- P/E ratio
- -4.34
- Dividend yield
- 0.00%
- 52-week range
- $5.15 – $16.45
- Volume
- 463.81K
- Avg. volume
- 275.51K
Price performance · TRDA
TRDA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
TRDA closed at $5.48 after 20 trading sessions, down 27.13% for the selected period.
- Last close
- $5.48
- Period change
- -27.13%
- Period low
- $5.38
- Period high
- $7.52
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $5.38 | $5.48 | $5.15 | $5.48 | 463.81K |
| Oct 2, 2026 | $5.77 | $6.22 | $5.1701 | $5.38 | 463.71K |
| Oct 1, 2026 | $6.32 | $6.36 | $5.6001 | $5.68 | 425.14K |
| Sep 30, 2026 | $6.20 | $6.39 | $6.125 | $6.35 | 239.86K |
| Sep 29, 2026 | $6.25 | $6.43 | $6.08 | $6.26 | 268.59K |
| Sep 28, 2026 | $6.13 | $6.24 | $5.925 | $6.22 | 442.59K |
| Sep 25, 2026 | $6.23 | $6.245 | $6.01 | $6.16 | 374.04K |
| Sep 24, 2026 | $6.47 | $6.47 | $6.14 | $6.22 | 319.12K |
| Sep 23, 2026 | $6.71 | $6.71 | $6.37 | $6.50 | 282.77K |
| Sep 22, 2026 | $6.71 | $6.9299 | $6.654 | $6.71 | 195.52K |
| Sep 21, 2026 | $6.81 | $6.81 | $6.455 | $6.64 | 375.3K |
| Sep 18, 2026 | $6.85 | $6.89 | $6.60 | $6.75 | 354.43K |
| Sep 17, 2026 | $6.91 | $7.05 | $6.665 | $6.90 | 297.36K |
| Sep 16, 2026 | $6.92 | $6.99 | $6.74 | $6.89 | 249.22K |
| Sep 15, 2026 | $7.05 | $7.05 | $6.67 | $6.88 | 247.77K |
| Sep 14, 2026 | $6.80 | $7.07 | $6.72 | $7.05 | 336.1K |
| Sep 11, 2026 | $6.49 | $6.81 | $6.29 | $6.80 | 291.81K |
| Sep 10, 2026 | $7.00 | $7.175 | $6.38 | $6.42 | 448.06K |
| Sep 9, 2026 | $7.47 | $7.55 | $7.02 | $7.11 | 382.04K |
| Sep 8, 2026 | $7.02 | $7.70 | $6.945 | $7.52 | 514.21K |
Latest TRDA news
The latest Smart Investors Daily articles mentioning TRDA.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

